Full Text View
Tabular View
No Study Results Posted
Related Studies
A Preliminary Study on Effect of Omega-3 on Human Sperm
This study is not yet open for participant recruitment.
Verified by Hadassah Medical Organization, November 2006
First Received: May 28, 2007   Last Updated: May 29, 2007   History of Changes
Sponsors and Collaborators: Hadassah Medical Organization
Shaare Zedek Medical Center
Information provided by: Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT00479960
  Purpose

The phospholipids of mammalian spermatozoa possess a distinctive fatty acid composition with high proportion of long chain polyunsaturated fatty acids.

The lipid composition is a major determinant of the membrane flexibility and sperm motility required for proper fertilization. It also influences the sperm plasma membrane's fluidity, chilling sensitivity and thermotropic lipid phase transition (LPT) and these parameters determine our ability to cryopreserve these cells. Our hypotheses is that by providing dietary supplementation of omega-3 polyunsaturated fatty acids an improvement of sperm parameters (number, motility, viability) can be achieved. We also expect alteration spermatozoal plasma membrane fatty acid composition, making it more chilling resistant. Experimental methodology: 1) Characterize fatty acid composition of the spermatozoa of normal and abnormal spermatozoa by gas chromatography. 2) Characterize sperm plasma membrane LPT by FTIR spectrometer. 3) Run a randomized double-blind, placebo controlled, crossed-over dietary fatty acid supplementation pilot trial in human sub-fertile patients. Large scale trial will follow, if justified. In both trials sperm characterization of each participant will be conducted before, during and following the trial. Subfertile males will benefit greatly if their sperm parameters can be improved and cryopreserved while ensuring enhanced post-thawing survival. We believe that changing the fatty acid composition of sperm plasma membrane by simple dietary means will open the way to improve the fertility of those that needs it the most.


Condition Intervention Phase
Oligospermia
Behavioral: commercially available omega-3 fatty acids supplementation
Phase 0

Genetics Home Reference related topics: Y chromosome infertility
MedlinePlus related topics: Dietary Supplements Diets
Drug Information available for: Docosahexaenoic acids Eicosapentaenoic acid
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study
Official Title: Effect of Dietary Supplementation With Omega-3 Fatty Acids on Human Sperm Characteristics, a Preliminary Study

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • sperm count [ Time Frame: 10 weeks ]

Secondary Outcome Measures:
  • sperm Lipid phase transition determination [ Time Frame: 10 weeks ]

Estimated Enrollment: 20
Study Start Date: June 2007
Estimated Study Completion Date: June 2007
  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients with asthenozoospermia (low progressive motility), teratozoopermia (abnormal morphology) and/or oligozoospermia (low sperm count)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00479960

Contacts
Contact: Abraham Benchetrit, MD 97250-8962566 benchet@012.net.il
Contact: Ariel Revel, MD 97226776424 arielrevel2@gmail.com

Locations
Israel
Shaare Zedek Medical Center
Jerusalem, Israel
Sponsors and Collaborators
Hadassah Medical Organization
Shaare Zedek Medical Center
Investigators
Principal Investigator: Ariel Revel, MD Hadassah university hospital
  More Information

No publications provided

Study ID Numbers: 022006
Study First Received: May 28, 2007
Last Updated: May 29, 2007
ClinicalTrials.gov Identifier: NCT00479960     History of Changes
Health Authority: Israel: Ethics Commission

Keywords provided by Hadassah Medical Organization:
Asthenozoospermia
Azoospermia
Oligospermia
Omega-3
Fatty Acids

Study placed in the following topic categories:
Infertility
Oligospermia
Azoospermia
Infertility, Male
Genital Diseases, Male
Spastic Paraplegia Epilepsy Mental Retardation

Additional relevant MeSH terms:
Infertility
Oligospermia
Infertility, Male
Genital Diseases, Male

ClinicalTrials.gov processed this record on May 07, 2009